Hospital
Molokai General Hospital
Molokai General Hospital was paid $14.48M by Medicaid between Jan 2018 and Dec 2024, across 98 billing codes. Its largest line is 99283, emergency room visit (moderate) — 41% of everything it billed.
33Billing provider infoMOLOKAI GENERAL HOSPITAL
KAUNAKAKAI, HI 96748
KAUNAKAKAI, HI 96748
33aNPI1366486979assigned 06/15/2006
33bProvider typeCritical Access Hospital
28Total paid$14.48M
24GClaims115,968
24DCodes billed98
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Hawaii
Rank by total paid#1 of 8
Median peer was paid$4.91M
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,831 | $1.11M | |
| 2019 | 16,881 | $1.36M | |
| 2020 | 11,616 | $1.05M | |
| 2021 | 16,841 | $1.85M | |
| 2022 | 18,017 | $2.73M | |
| 2023 | 19,638 | $3.20M | |
| 2024incomplete | 16,144 | $3.19M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 41% | 8,594 | 7,511 | $5.90M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 3,771 | 3,176 | $3.27M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 13% | 4,129 | 3,798 | $1.90M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 2,098 | 1,644 | $1.68M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.1% | 11,916 | 9,223 | $447K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 86 | 75 | $201K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 2,867 | 1,051 | $181K |
| 80053 | Comprehensive metabolic panel | 1.2% | 9,440 | 7,790 | $180K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 293 | 245 | $116K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 876 | 619 | $94K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,361 | 526 | $76K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 112 | 105 | $45K |
86 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,119 | $43K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,412 | $42K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 812 | $38K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,609 | $37K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,995 | $24K |
| 85027 | <1% | 291 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 626 | $13K |
| 0001A | <1% | 309 | $12K | |
| 0002A | <1% | 269 | $11K | |
| 97161 | <1% | 94 | $11K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 160 | $11K |
| 81001 | <1% | 4,341 | $11K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,478 | $10K |
| 81025 | <1% | 1,783 | $10K | |
| 84550 | <1% | 752 | $9K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 33 | $9K |
| 85610 | <1% | 1,599 | $8K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,797 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 431 | $6K |
| 85018 | <1% | 227 | $6K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 63 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 695 | $5K |
| 0064A | <1% | 161 | $5K | |
| 0012A | <1% | 127 | $5K | |
| 0011A | <1% | 149 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,130 | $3K |
| 0071A | <1% | 84 | $3K | |
| 0072A | <1% | 76 | $3K | |
| 86900 | <1% | 51 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,005 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 612 | $2K |
| Q3014 | Telehealth originating site facility fee | <1% | 277 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 918 | $2K |
| 83880 | <1% | 54 | $2K | |
| 0054A | <1% | 32 | $1K | |
| 0004A | <1% | 33 | $1K | |
| 97597 | <1% | 23 | $1K | |
| 97162 | <1% | 13 | $1K | |
| 84484 | <1% | 1,792 | $717.75 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 44 | $573.98 |
| 80076 | <1% | 20 | $319.29 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 727 | $304.40 |
| 83690 | <1% | 1,207 | $299.34 | |
| 81002 | <1% | 55 | $282.12 | |
| 0134A | <1% | 14 | $171.76 | |
| 85651 | <1% | 27 | $72.08 | |
| 96160 | <1% | 5,592 | $58.90 | |
| 83605 | <1% | 464 | $52.16 | |
| G0378 | Hospital observation service, per hour | <1% | 27 | $51.48 |
| 87040 | <1% | 140 | $17.96 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 532 | $17.32 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 800 | $14.71 |
| 86140 | <1% | 35 | $14.43 | |
| 82948 | <1% | 49 | $9.18 | |
| 87070 | <1% | 128 | $7.51 | |
| 86850 | <1% | 49 | $7.22 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 352 | $6.45 |
| 86901 | <1% | 52 | $2.73 | |
| J9999 | Not otherwise classified, antineoplastic drugs | <1% | 95 | $2.00 |
| J3490 | Unclassified drugs | <1% | 7,591 | $0.84 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 119 | $0.22 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 220 | $0.12 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 30 | $0.00 |
| 96161 | 0% | 2,041 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 823 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 15 | $0.00 |
| 96376 | 0% | 169 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 17 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 44 | $0.00 |
| 83735 | 0% | 38 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 113 | $0.00 |
| 82962 | 0% | 16 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 16 | $0.00 |
| A9150 | Non-prescription drugs | 0% | 26 | $0.00 |
| 85014 | 0% | 355 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 165 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 17 | $0.00 |
| S1015 | Iv tubing extension set | 0% | 135 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 162 | $0.00 |
| A9999 | Miscellaneous dme supply or accessory, not otherwise specified | 0% | 95 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 14 | $0.00 |
| A4663 | Blood pressure cuff only | 0% | 193 | $0.00 |
| S5170 | Home delivered meals, including preparation; per meal | 0% | 12 | $0.00 |
| A4606 | Oxygen probe for use with oximeter device, replacement | 0% | 115 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 16 | $0.00 |
| 87186 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKALANIHUIA, JANICE (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Molokai General Hospital | Kaunakakai, HI | $3.06M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.